Aerosol administration increases the efficacy of oseltamivir for the treatment of mice infected with influenza viruses.

about

Combined aerosolized Toll-like receptor ligands are an effective therapeutic agent against influenza pneumonia when co-administered with oseltamivir.

P2860

Q47601706-1DC3AF74-5F33-44D3-A3C1-66DB9043E9C4

P2860

Aerosol administration increases the efficacy of oseltamivir for the treatment of mice infected with influenza viruses.

Item

http://www.wikidata.org/entity/Q38912274

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Aerosol administration increas ...... fected with influenza viruses.

@en

type

Item

label

Aerosol administration increas ...... fected with influenza viruses.

@en

prefLabel

Aerosol administration increas ...... fected with influenza viruses.

@en

P1476

Aerosol administration increas ...... nfected with influenza viruses

@en

P2093

Peter Palese

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomers

Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir

Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection.

Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses

A novel small molecule inhibitor of influenza A viruses that targets polymerase function and indirectly induces interferon

Contemporary avian influenza A virus subtype H1, H6, H7, H10, and H15 hemagglutinin genes encode a mammalian virulence factor similar to the 1918 pandemic virus H1 hemagglutinin.

Advances in the development of influenza virus vaccines.

Direct administration in the respiratory tract improves efficacy of broadly neutralizing anti-influenza virus monoclonal antibodies.

Clinical management of pandemic 2009 influenza A(H1N1) infection.

Introduction of virulence markers in PB2 of pandemic swine-origin influenza virus does not result in enhanced virulence or transmission.

P304

12-15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.ANTIVIRAL.2017.03.002

http://www.w3.org/2001/XMLSchema#string

P478

142

http://www.w3.org/2001/XMLSchema#string

P50

Victor H Leyva-Grado

P577

2017-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28286235

http://www.w3.org/2001/XMLSchema#string

P921

aerosol

P932

5477427

http://www.w3.org/2001/XMLSchema#string

Aerosol administration increases the efficacy of oseltamivir for the treatment of mice infected with influenza viruses.

about

P2860

P2860

Aerosol administration increases the efficacy of oseltamivir for the treatment of mice infected with influenza viruses.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932